HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Superfluous” Country-Of-Origin Labeling Would Confuse Consumers – NACDS

This article was originally published in The Tan Sheet

Executive Summary

Requiring country-of-origin labeling on OTCs, dietary supplements and other food and drug products is overly burdensome and could hinder firms' inventory maintenance as well as confuse consumers, the National Association of Chain Drug Stores says

You may also be interested in...



Country-Of-Origin Labeling Would Add Costs But No Consumer Benefit – CRN

Requiring country-of-origin labeling for dietary supplements would be redundant with good manufacturing practices and could raise prices without benefiting consumers, according to the Council for Responsible Nutrition

FDA Globalization Bill Should Focus On “Greatest Risk” Foods – CFSAN

Draft legislation to comprehensively reform FDA enforcement and inspection powers should focus more on high-risk foods than on general changes to food safety oversight, according to Stephen Sundlof, director of the agency's Center for Food Safety and Applied Nutrition

Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing

The dietary supplement good manufacturing practices final rule provides "a very flexible framework for required testing," said Vasilios H. Frankos, director of the dietary supplement programs division for FDA's Center for Food Safety and Applied Nutrition

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel